Sone-296 Updated

| Model | Species | Dosing Regimen | Efficacy Readout | Key Result | |-------|--------|----------------|------------------|------------| | (e.g., tumor cell line panel) | – | 0.1‑10 µM | Viability (MTT) | IC₅₀ = 30 nM in XYZ line | | Xenograft (e.g., human A‑cell line in nude mice) | Mouse | 10 mg/kg PO daily | Tumor volume reduction | ‑78 % vs. control at Day 21 | | PDX (patient‑derived xenograft) | Mouse | 25 mg/kg PO QD | Survival extension | Median OS ↑ 3.2 months | | Safety‑toxicity (GLP repeat‑dose) | Rat / Dog | 0‑100 mg/kg | No‑observed‑adverse‑effect‑level (NOAEL) | ≥50 mg/kg |

At first glance, SONE-296 appears to be a random combination of characters. However, upon closer inspection, it is clear that this term has been generating significant interest online. Some individuals have reported encountering SONE-296 in various contexts, including online forums, social media platforms, and even cryptic messages. Despite its seemingly obscure nature, SONE-296 has become a topic of fascination for many, sparking heated discussions and debates. SONE-296